#TissueDiagnostics

[alokahkumar]

The Tissue Diagnostics Market is segmented By Product (Reagents & Consumables and Instruments), Technology, Application, and Geography.

To know more Click Here https://bit.ly/3do3SrT

[myblogscoop]

Growth of Tissue Diagnostics Market -Global Industry Forecast to 2024

[27-Nov-2019]Meticulous Research® – a market research company is researching a study titled “Tissue Diagnostics Market by Product (Consumables, Instruments), Technology (Immunohistochemistry, in Situ Hybridization, Digital Pathology & Workflow), Disease (Breast Cancer, Gastric Cancer, Lymphoma), End User (Hospital, CRO) - Global Forecast to 2024”.

Key Findings in the Global Tissue Diagnostics Market

In its preliminary finding it found that the tissue diagnostics market is highly competitive and is rapidly gaining traction. The growth of this market is mainly owing to the inflation in cancer patients, improving infrastructure for cancer diagnosis, increasing healthcare expenditure, and technological advancements in tissue diagnostics. In recent years, this market has witnessed significant new product launches by key players to broaden their product portfolios, advance the capabilities of their existing products, and ensure a competitive edge in the tissue diagnostics market.

Get Free Sample Copy of This Report at: https://www.meticulousresearch.com/request-sample-report/cp_id=4971

Increasing Healthcare Expenditure Drives the Growth of Global Tissue Diagnostics Market

According to the World Health Organization’s (WHO) Global Health Expenditure database, overall expenditure on healthcare services has increased significantly in the recent years. Moreover, healthcare spending in developing countries is expected to rise exponentially by 2030.

Aging population is the major factor responsible for the increasing pressure on healthcare costs. Emerging markets are projected to age at approximately twice as fast as citizens in developed markets. As a result, by 2035, the share of the population aged 65 or older in countries such as China and Russia should be similar to that in countries such as the U.K. and the U.S. China is expected to witness substantial growth in healthcare spending from $611 billion in 2015 to $2.3 trillion in 2030. Thus, growing healthcare expenditure along with rising burden of cancer would propel the tissue diagnostics market during the forecast period.

Consumables Dominates the Market, By Product

Consumables accounted for the largest market share (%) over instruments, owing to the recurring need of consumables and technological advances in the development of novel consumables.

Immunohistochemistry Segment Dominates Market, By Technology

In 2018, immunohistochemistry commanded the largest market share (%) as compared to in situ hybridization, digital pathology and workflow management, H&E staining, and special staining. The largest share of immunohistochemistry is mainly attributed to the wide adoption of immunodiagnostics tests and point of care diagnostic tests.

Hospitals Leads the Adoption of Tissue Diagnostics

Based on end user, tissue diagnostics market is segmented into hospitals, research laboratories, pharmaceutical companies, contract research organization, ambulatory surgical centers, and others. Hospitals commanded the largest market share (%) of the global market in 2018. This is mainly attributed to significant patient pool treated in hospitals, increasing number of hospitals across the globe, and better accessibility and availability of various test results in hospitals.

North America Dominates the Global Tissue Diagnostics Market

In 2017, North America dominated the global tissue diagnostics market followed by Europe. However, Asia-Pacific is expected to grow with the highest CAGR during the projected period with growth centered at Japan, China, and India. Factors supporting the growth for this region include the growing healthcare expenditure, government support, rising prevalence of cancer, improving healthcare infrastructure, and rising focus of leading players in APAC region.

Key Players

The key players being studied in the global tissue diagnostics market study are F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), Abbott Laboratories (U.S.), Agilent Technologies, Inc. (U.S.), Merck KGaA (Germany), Sakura Finetek Japan Co., Ltd. (Japan), Abcam plc. (U.K.), Becton, Dickinson, and Company (U.S.), QIAGEN (The Netherlands), Bio SB (U.S.), BioGenex (U.S.), Cell Signaling Technology, Inc. (U.S.), 3DHISTECH Ltd. (Hungary), and Cancer Genetics Inc.(U.S.). 

Browse the in-depth Report at: https://www.meticulousresearch.com/product/tissue-diagnostics-market-4971/

About Us:

The name of our company defines our services, strengths, and values. Since the inception, we have endeavoured to research, analyze and present the critical market data with great attention to details.

Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, with the help of its unique research methodologies, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa regions.

With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.

Contact Us:  Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Website: https://www.meticulousresearch.com/ Connect with us | LinkedIn | Twitter

[researchswatistuff]

Tissue Diagnostics Market to be Worth $8.52 Billion by 2029

Meticulous Research®—a leading global market research company, published a research report titled, ‘Tissue Diagnostics Market by Product Type (Antibodies, Kits, Reagents, Instruments [Slide Stainer, Scanner]), Technology (Digital Pathology, IHC, ISH, H&E Staining), Cancer Type (Breast, NSCLC, Colorectal, Prostate), End user -Global Forecast to 2029’.

According to this latest publication from Meticulous Research, the global tissue diagnostics market is projected to reach $8.52 billion by 2029, at a CAGR of 7.4%. The rising prevalence of cancer globally, the availability of biomarkers and research on biomarkers, recommendations for cancer screening, the growing number of clinical trials for oncology drugs, and the availability of tissue-based companion diagnostics are the factors driving the growth of this market.                                              

Download Free PDF Sample Copy of the Report (with COVID-19 Impact Analysis):  https://www.meticulousresearch.com/download-sample-report/cp_id=4971

Scope of the Report:

Tissue Diagnostics Market, by Product Type

·         Consumables

o    Antibodies

o    Kits

o    Reagents

·         Instruments

o    Slide Staining Systems

o    Slide Scanners

o    Tissue Processors

o    Other Instruments Note: Other instruments include microarrays and embedding systems.

Tissue Diagnostics Market, by Technology

·         Immunohistochemistry (IHC)

·         In-situ Hybridization (ISH)

·         Digital Pathology

·         H&E Slide Staining

·         Other Technologies Note: Other technologies include molecular, immunofluorescence, and special staining

Tissue Diagnostics Market, by Application

·         Breast Cancer

·         Lung Cancer

·         Colorectal and Gastrointestinal Cancer

·         Prostate Cancer

·         Lymphatic Cancer

·         Other Applications Note: Other applications include cervical cancer, melanoma, lip, oral cavity cancer

Tissue Diagnostics Market, by End User

·         Hospitals and Reference Laboratories

·         Research Institutes

·         Pharmaceutical Companies

·         Contract Research Organization

Tissue Diagnostics Market, by Geography

·         North America 

o    U.S.

o    Canada 

·         Europe 

o    Germany

o    U.K.

o    France

o    Italy

o    Spain

o    Rest of Europe (RoE) 

·         Asia-Pacific (APAC) 

o    China

o    Japan

o    India

o    Rest of APAC (RoAPAC) 

·         Latin America

·         Middle East & Africa

To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/tissue-diagnostics-market-4971

Tissue Diagnostics Market: Future Outlook

The global tissue diagnostics market is segmented by Product Type (Consumables [Antibodies, Kits, Reagents], Instruments [Slide Staining Systems, Slide Scanners, Tissue Processing Systems, Other Instruments {Microarray, Embedding System]), Technology (Immunohistochemistry, In-situ Hybridization, Digital Pathology, H&E Slide Staining, Other Technologies, Application (Breast Cancer, Lung Cancer, Colorectal and Gastrointestinal Cancer, Prostate Cancer, Lymphatic Cancer, Other Applications), End User (Hospitals and Reference Laboratories, Research Institutes, Pharmaceutical Companies, and Contract Research Organization). The study also evaluates industry competitors and analyzes their market shares at the global and regional levels.

Based on product, in 2022, the consumables segment is expected to account for the largest share of the market. The extensive and recurring requirement of consumables and technological advances in developing novel reagents contribute to the large market share of this segment.

Based on technology, the tissue diagnostics market is segmented into immunohistochemistry, in-situ hybridization, digital pathology, H&E staining, and other technologies. In 2022, the immunohistochemistry segment is expected to account for the largest share of the global tissue diagnostics market. Developments in in-vitro diagnostics and the upsurge in point-of-care diagnostics are the factors contributing to the growth of this segment.

Request Sample Report: https://www.meticulousresearch.com/request-sample-report/cp_id=4971

Based on application, the tissue diagnostics market is segmented into breast cancer, lung cancer, colorectal and gastrointestinal cancer, prostate cancer, lymphatic cancer, and other applications. In 2022, the breast cancer segment is expected to account for the largest share of the global tissue diagnostics market. The growth of this segment is attributed to the high prevalence of breast cancer and the presence of several research and screening programs for combating breast cancer.

Based on end user, in 2022, the hospital and reference laboratories segment is expected to account for the largest share of the market. The large market share of this segment is attributed to the high inflow of patients and tests due to the increasing prevalence of cancer.

This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), Latin America, and the Middle East & Africa. In 2022, North America is expected to account for the largest share of the tissue diagnostics market. The large market share of this regional market is driven by the high cancer prevalence, easy accessibility to advanced technologies, and the presence of public programs for cancer management.

The key players operating in the global tissue diagnostics market are F. Hoffmann-La Roche Ltd (Switzerland), Danaher Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), Abbott Laboratories (U.S.), Agilent Technologies, Inc. (U.S.), Merck KGaA (Sigma-Aldrich Co. LLC) (Germany), Sakura Finetek Japan Co., Ltd. (Japan), Abcam plc (U.K.), Becton, Dickinson, and Company (U.S.), QIAGEN N.V. (Netherlands), Cell Signaling Technology, Inc. (U.S.), Bio-Genex Laboratories, Inc. (U.S.), Bio SB, INC (U.S.), 3DHISTECH Ltd. (Hungary), and HOLOGIC, INC. (U.S.)

Key questions answered in the report-

·  Which are the high-growth market segments in terms of product type, technology, application, end user, and regions/countries?

·  What was the historical market for tissue diagnostics across the globe?

·  What are the market forecasts and estimates for the period 2022–2029?

·  What are the major drivers, restraints, challenges, opportunities, and trends in the global tissue diagnostics market?

·  Who are the major players in the global tissue diagnostics market?

·  How is the competitive landscape, and who are the market leaders in the global tissue diagnostics market?

·  What are the recent developments in the tissue diagnostics market?

·  What are the different strategies adopted by the major players in the tissue diagnostics market?

·  What are the geographical trends and high-growth regions/countries?

You can Buy Report from Here: https://www.meticulousresearch.com/Checkout/27604669

Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research